Literature DB >> 1771215

Effects of MK-801 stereoisomers on schedule-controlled behavior in rats.

R F Genovese1, X C Lu.   

Abstract

Behavioral effects of (+)MK-801 (0.03-0.32 mg/kg) and (-)MK-801 (0.32-3.20 mg/kg) were evaluated in rats using a multiple fixed-ratio, fixed-interval (FR20, FI2) schedule of food presentation. Both enantiomers produced dose-dependent decreases in response rate under the FR20 and in this respect (+)MK-801 was approximately ten times as potent as (-)MK-801. Under the FI2 schedule component, the (+) enantiomer produced substantial increases as well as decreases in response rate whereas the (-) enantiomer produced only decreases. When 0.178 mg/kg (+)MK-801 and 1.78 mg/kg (-)MK-801 were administered for 11 consecutive days, tolerance developed to the decrease in response rate under the FR20 schedule component. Tolerance to the effects of the (+) enantiomer under the FI2 schedule component was indicated by progressively larger increases in response rate than those observed during acute administration. These results support potential therapeutic applications of MK-801.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1771215     DOI: 10.1007/bf02244366

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning.

Authors:  M Morelli; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Amnesic effect of the novel anticonvulsant MK-801.

Authors:  M J Benvenga; T C Spaulding
Journal:  Pharmacol Biochem Behav       Date:  1988-05       Impact factor: 3.533

3.  N-methyl-D-aspartate antagonist MK801 improves outcome following traumatic spinal cord injury in rats: behavioral, anatomic, and neurochemical studies.

Authors:  A I Faden; M Lemke; R P Simon; L J Noble
Journal:  J Neurotrauma       Date:  1988       Impact factor: 5.269

4.  Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.

Authors:  W Koek; F C Colpaert
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

5.  Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage.

Authors:  M P Papagapiou; R N Auer
Journal:  J Cereb Blood Flow Metab       Date:  1990-03       Impact factor: 6.200

6.  Effects of NMDA receptor antagonists following spinal ischemia in the rabbit.

Authors:  A Martinez-Arizala; D D Rigamonti; J B Long; J M Kraimer; J W Holaday
Journal:  Exp Neurol       Date:  1990-06       Impact factor: 5.330

7.  MK-801 impedes the acquisition of a spatial memory task in rats.

Authors:  R L McLamb; L R Williams; K P Nanry; W A Wilson; H A Tilson
Journal:  Pharmacol Biochem Behav       Date:  1990-09       Impact factor: 3.533

8.  Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats.

Authors:  K T Brady; R L Balster; E L May
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

9.  MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

Authors:  W Koek; J H Woods; G D Winger
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

10.  Quantitative assessment of neuroprotection against NMDA-induced brain injury.

Authors:  J W McDonald; N F Roeser; F S Silverstein; M V Johnston
Journal:  Exp Neurol       Date:  1989-12       Impact factor: 5.330

View more
  1 in total

1.  Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.

Authors:  Shashank M Dravid; Kevin Erreger; Hongjie Yuan; Katherine Nicholson; Phuong Le; Polina Lyuboslavsky; Antoine Almonte; Ernest Murray; Cara Mosely; Jeremy Barber; Adam French; Robert Balster; Thomas F Murray; Stephen F Traynelis
Journal:  J Physiol       Date:  2007-02-15       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.